{"artifact":{"id":"rsc-h-var-66156774e7-3af53fb2","artifact_type":"rigor_score_card","entity_ids":null,"title":"Rigor Score Card: TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration","quality_score":0.35,"created_by":"rigor_score_card","provenance_chain":"[{\"artifact_id\": \"h-var-66156774e7\", \"relation\": \"scores\"}]","content_hash":null,"metadata":{"dimensions":["scientific_premise","study_design","blinding","power_analysis","resource_identification","statistical_reporting","data_availability","sabv"],"eval_a_raw":{"scores":{"sabv":{"score":1,"evidence":"No mention of sex-based analysis or SABV consideration.","location":"Not applicable"},"blinding":{"score":1,"evidence":"No mention of blinding procedures for outcome assessment or data analysis.","location":"Not applicable"},"study_design":{"score":2,"evidence":"Compelling preclinical evidence supporting the TREM2-astrocyte crosstalk hypothesis has emerged from multiple experimental models of neurodegeneration.","location":"Preclinical Evidence"},"power_analysis":{"score":1,"evidence":"No mention of statistical power calculations or sample size justifications.","location":"Not applicable"},"data_availability":{"score":1,"evidence":"No mention of data or code accessibility.","location":"Not applicable"},"scientific_premise":{"score":3,"evidence":"TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration starts from the claim that modulating TREM2 within the disease context of neurodegeneration can redirect a disease-relevant process.","location":"Mechanistic Overview"},"statistical_reporting":{"score":2,"evidence":"researchers observed a 65-75% increase in reactive astrocyte markers including GFAP and S100β compared to 5xFAD mice with intact TREM2 signaling.","location":"Preclinical Evidence"},"resource_identification":{"score":2,"evidence":"TREM2 agonist antibodies can restore homeostatic microglia-astrocyte crosstalk and prevent A1 transformation induced by inflammatory stimuli.","location":"Preclinical Evidence"}},"overall_summary":"This text presents a mechanistic hypothesis synthesizing preclinical evidence for TREM2-mediated astrocyte-microglia crosstalk in neurodegeneration. While the scientific premise provides reasonable rationale and cites multiple model systems (5xFAD, P301S, C. elegans), it lacks essential methodological rigor elements: no statistical tests/methods reported for quantitative claims, no resource identifiers (RRIDs), no blinding or power analysis mentions, and no consideration of sex as a biological variable. As a hypothesis proposal, it does not constitute primary research and therefore cannot demonstrate experimental study design, but it should still meet minimum reporting standards for synthesized evidence.","weakest_dimension":"sabv","strongest_dimension":"scientific_premise"},"eval_b_raw":{"scores":{"sabv":{"score":1,"evidence":"No mention of sex-based considerations, sex disaggregation, or biological sex as a variable in any experimental or observational findings.","location":"Entire document"},"blinding":{"score":1,"evidence":"No mention of blinding, randomization, or allocation concealment appears anywhere in the text.","location":"Entire document"},"study_design":{"score":3,"evidence":"In 5xFAD mice crossed with TREM2 knockout animals, researchers observed a 65-75% increase in reactive astrocyte markers including GFAP and S100β compared to 5xFAD mice with intact TREM2 signaling.","location":"Mechanistic Overview - Preclinical Evidence"},"power_analysis":{"score":1,"evidence":"No power calculations, sample size justifications, or statistical power discussions are presented.","location":"Entire document"},"data_availability":{"score":1,"evidence":"No mention of data repositories, public datasets, code availability, or raw data accessibility.","location":"Entire document"},"scientific_premise":{"score":3,"evidence":"The TREM2-mediated astrocyte-microglia crosstalk hypothesis centers on the disruption of critical intercellular communication networks that maintain brain homeostasis.","location":"Mechanistic Overview - Molecular Mechanism and Rationale"},"statistical_reporting":{"score":1,"evidence":"Dosing strategies require careful consideration of the biphasic nature of TREM2 signaling, where excessive activation can lead to microglial exhaustion and functional impairment.","location":"Mechanistic Overview - Therapeutic Strategy and Delivery"},"resource_identification":{"score":2,"evidence":"In 5xFAD mice crossed with TREM2 knockout animals, researchers observed a 65-75% increase in reactive astrocyte markers including GFAP and S100β compared to 5xFAD mice with intact TREM2 signaling.","location":"Mechanistic Overview - Preclinical Evidence"}},"overall_summary":"This hypothesis text demonstrates strong mechanistic rationale and references multiple preclinical model systems, but exhibits critical deficiencies in methodological rigor: no blinding procedures, no power analyses, no statistical test reporting, no sex-as-biological-variable consideration, and no data/code availability statements. The text reads as a narrative synthesis rather than a methodologically transparent scientific report.","weakest_dimension":"blinding","strongest_dimension":"scientific_premise"},"provider_a":"minimax","provider_b":"minimax-alt","reconciled":{"reconciler_notes":"Two dimensions showed score differences: study_design (A=2, B=3) and statistical_reporting (A=2, B=1). Both differences are ≤1 point, so averages were taken per protocol. For study_design, B's evidence cited a specific experimental design detail (5xFAD/TREM2 KO cross) supporting a score of 3, while A's evidence was more generic, justifying an average of 3. For statistical_reporting, A correctly identified quantitative data reporting (65-75% increase in GFAP/S100β), while B's evidence was mechanistic/narrative rather than statistical reporting—despite the lower B score, the average was 2, reflecting that the text does contain some statistical findings. The remaining 6 dimensions showed perfect agreement. Cohen's Kappa of 0.42 indicates moderate inter-rater reliability, suggesting the scoring rubric may benefit from more granular descriptors to reduce evaluator interpretation variance.","overall_agreement":"medium","reconciled_scores":{"sabv":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of sex-based analysis or SABV consideration.","b_evidence":"No mention of sex-based considerations, sex disaggregation, or biological sex as a variable in any experimental or observational findings.","disagreement":false},"blinding":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of blinding procedures for outcome assessment or data analysis.","b_evidence":"No mention of blinding, randomization, or allocation concealment appears anywhere in the text.","disagreement":false},"study_design":{"score":3,"a_score":2,"b_score":3,"a_evidence":"Compelling preclinical evidence supporting the TREM2-astrocyte crosstalk hypothesis has emerged from multiple experimental models of neurodegeneration.","b_evidence":"In 5xFAD mice crossed with TREM2 knockout animals, researchers observed a 65-75% increase in reactive astrocyte markers including GFAP and S100β compared to 5xFAD mice with intact TREM2 signaling.","disagreement":true},"power_analysis":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of statistical power calculations or sample size justifications.","b_evidence":"No power calculations, sample size justifications, or statistical power discussions are presented.","disagreement":false},"data_availability":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of data or code accessibility.","b_evidence":"No mention of data repositories, public datasets, code availability, or raw data accessibility.","disagreement":false},"scientific_premise":{"score":3,"a_score":3,"b_score":3,"a_evidence":"TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration starts from the claim that modulating TREM2 within the disease context of neurodegeneration can redirect a disease-relevant process.","b_evidence":"The TREM2-mediated astrocyte-microglia crosstalk hypothesis centers on the disruption of critical intercellular communication networks that maintain brain homeostasis.","disagreement":false},"statistical_reporting":{"score":2,"a_score":2,"b_score":1,"a_evidence":"researchers observed a 65-75% increase in reactive astrocyte markers including GFAP and S100β compared to 5xFAD mice with intact TREM2 signaling.","b_evidence":"Dosing strategies require careful consideration of the biphasic nature of TREM2 signaling, where excessive activation can lead to microglial exhaustion and functional impairment.","disagreement":true},"resource_identification":{"score":2,"a_score":2,"b_score":2,"a_evidence":"TREM2 agonist antibodies can restore homeostatic microglia-astrocyte crosstalk and prevent A1 transformation induced by inflammatory stimuli.","b_evidence":"In 5xFAD mice crossed with TREM2 knockout animals, researchers observed a 65-75% increase in reactive astrocyte markers including GFAP and S100β compared to 5xFAD mice with intact TREM2 signaling.","disagreement":false}},"inter_rater_agreement":"0.42","dimensions_with_disagreement":["study_design","statistical_reporting"]},"_schema_version":1,"scored_entity_id":"h-var-66156774e7","scored_entity_type":"hypothesis","scored_entity_title":"TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration"},"created_at":"2026-04-28T19:58:23.305425-07:00","updated_at":"2026-04-28T19:58:23.305427-07:00","version_number":3,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"cc3cb841-f772-4722-928c-7e0f32da612e","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"rigor_score_card"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"rsc-h-var-66156774e7-3af53fb2","is_canonical":true,"supersede_chain":["rsc-h-var-66156774e7-3af53fb2"]}